Cargando…
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem‐cell‐derived organoids
Mitochondrial DNA (mtDNA) diseases are multi‐systemic disorders caused by mutations affecting a fraction or the entirety of mtDNA copies. Currently, there are no approved therapies for the majority of mtDNA diseases. Challenges associated with engineering mtDNA have in fact hindered the study of mtD...
Autores principales: | Tolle, Isabella, Tiranti, Valeria, Prigione, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074100/ https://www.ncbi.nlm.nih.gov/pubmed/36876467 http://dx.doi.org/10.15252/embr.202255678 |
Ejemplares similares
-
Gene Editing in Pluripotent Stem Cells and Their Derived Organoids
por: Zhou, Hang, et al.
Publicado: (2021) -
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
por: Bottani, Emanuela, et al.
Publicado: (2020) -
High-content screening of mitochondrial polarization in neural cells derived from human pluripotent stem cells
por: Zink, Annika, et al.
Publicado: (2022) -
Modeling human development and disease in pluripotent stem cell-derived gastric organoids
por: McCracken, Kyle W., et al.
Publicado: (2014) -
Pluripotent stem cell‐derived retinal organoids for disease modeling and development of therapies
por: Kruczek, Kamil, et al.
Publicado: (2020)